XOMA Royalty Corp
XOMA26.960USD
+0.850+3.26%
Fechamento 07/03, 13:00（ET）Cotações atrasadas em 15 min
322.25MValor de mercado
PerdaP/L TTM
Mais detalhes de XOMA Royalty Corp Empresa
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), Cetrelimab (JNJ-63723283), Ersodetug (RZ358), MIPLYFFATM (arimoclomol), Acimtamig (AFM13), Ficlatuzumab (AV-299), COM902, Vosaroxin, Aldoxorubicin, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, DSUVIA (sufentanil sublingual tablet), IXINITY, Vidutolimod (CMP-001), MT-0169, RZ-402, G03-52-0, AFM24, Mezagitamab (TAK-079), among others. The Company also acquires milestone and royalty revenue streams on late-stage or commercial assets.
Informações da empresa
Código da empresaXOMA
Nome da EmpresaXOMA Royalty Corp
Data de listagemJun 06, 1986
Fundado em2011
CEOMr. Owen P. Hughes, Jr.
Número de funcionários13
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 06
Endereço2200 Powell Street
CidadeEMERYVILLE
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal94608
Telefone15102047239
Sitehttps://www.xoma.com/
Código da empresaXOMA
Data de listagemJun 06, 1986
Fundado em2011
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Mr. Owen P. Hughes, Jr.
Mr. Owen P. Hughes, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bradley J. (Brad) Sitko
Mr. Bradley J. (Brad) Sitko
Chief Investment Officer
Chief Investment Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: qua, 2 de jul
Moeda: USDAtualizado em: qua, 2 de jul
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
6.09M
38.30%
Switzerland
5.82M
36.56%
Asia Pacific
4.00M
25.14%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qui, 22 de mai
Atualizado em: qui, 22 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
Investidores
Investidores
Proporção
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
Tipos de investidores
Investidores
Proporção
Hedge Fund
26.12%
Investment Advisor/Hedge Fund
18.89%
Investment Advisor
17.15%
Individual Investor
1.34%
Research Firm
0.34%
Pension Fund
0.08%
Bank and Trust
0.07%
Insurance Company
0.02%
Other
35.99%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
147
7.66M
64.02%
+67.58K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
2023Q1
155
7.51M
65.57%
+97.45K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BVF Partners L.P.
2.59M
21.65%
-392.72K
-13.17%
May 16, 2025
Morgan Stanley Investment Management Inc. (US)
1.10M
9.23%
+811.40K
+277.18%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.04M
8.68%
-1.68K
-0.16%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
490.59K
4.1%
-8.20K
-1.64%
Mar 31, 2025
The Vanguard Group, Inc.
459.09K
3.84%
-4.75K
-1.02%
Mar 31, 2025
Opaleye Management Inc.
253.04K
2.11%
+3.04K
+1.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
186.67K
1.56%
+4.48K
+2.46%
Mar 31, 2025
Woodline Partners LP
168.55K
1.41%
+12.28K
+7.86%
Mar 31, 2025
State Street Global Advisors (US)
144.73K
1.21%
+200.00
+0.14%
Mar 31, 2025
Stonepine Capital Management, LLC
129.81K
1.08%
+4.11K
+3.27%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qua, 2 de jul
Atualizado em: qua, 2 de jul
Nome
Proporção
iShares Micro-Cap ETF
0.04%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
Ver Mais
iShares Micro-Cap ETF
Proporção0.04%
ProShares Hedge Replication ETF
Proporção0.01%
iShares Russell 2000 ETF
Proporção0.01%
iShares Russell 2000 Growth ETF
Proporção0.01%
iShares Russell 2000 Value ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Global X Russell 2000 ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%
Avantis US Equity ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
